4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-046906
Chief Accounting Officer sold 953 shares at an average $0.75 ($715)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-19 | Sale : show line 1 in the form | −473 | $0.75 | $355 | 78,099 | D |
| 2024-04-22 | Sale : show line 2 in the form | −480 | $0.75 | $360 | 77,619 | D |
| Open-market sales · 953 sh · avg $0.75 · $715 | ||||||
Loading xslF345X05/ownership.xml…